A patient with poorly controlled diabetes presents with an HbA1c level of 9.2% and a tingling sensation in her feet. Considering her current health status, which intervention should the nurse prioritize to prevent further complications?

B) Educate the patient on the importance of strict glycemic control and foot care.

A) Increase the dose of atorvastatin to manage elevated LDL cholesterol.

B) Educate the patient on the importance of strict glycemic control and foot care.

C) Suggest a high-protein diet to improve overall metabolic function.

D) Recommend daily foot massages to alleviate tingling sensations.

A 54-year-old female patient with type 2 diabetes mellitus presents with an HbA1c level of 9.2% and LDL cholesterol level of 140 mg/dL despite adherence to atorvastatin therapy. She also reports tingling in her feet, and a monofilament test indicates decreased sensation. Which intervention should the nurse prioritize to address the patient's current complications and prevent further progression?

B) Recommend initiating a GLP-1 receptor agonist to improve glycemic control and provide cardiovascular benefits.

A) Educate the patient about increasing her atorvastatin dosage to further lower LDL cholesterol levels.

B) Recommend initiating a GLP-1 receptor agonist to improve glycemic control and provide cardiovascular benefits.

C) Suggest daily foot inspections and the use of comfortable footwear to prevent diabetic foot ulcers.

D) Advise increasing dietary fiber intake to help manage blood glucose levels.

A patient with type 2 diabetes has been started on a GLP-1 receptor agonist. She reports experiencing nausea, a common side effect of the medication. Which nursing intervention is most appropriate to help manage this side effect and improve medication adherence?

C) Suggest taking the medication with a meal

A) Advise the patient to take the medication on an empty stomach

B) Recommend taking the medication with a full glass of water

C) Suggest taking the medication with a meal

D) Encourage the patient to stop the medication until nausea subsides

A patient with type 2 diabetes has been started on a GLP-1 receptor agonist and reports occasional nausea as a side effect. Despite improvements in fasting blood glucose levels, her LDL cholesterol remains elevated, and she experiences persistent tingling in her feet. Which nursing intervention should be prioritized to address her current concerns and improve her overall management plan?

B) Suggest the patient take her GLP-1 receptor agonist with meals to manage nausea.

A) Educate the patient about dietary adjustments to help lower LDL cholesterol.

B) Suggest the patient take her GLP-1 receptor agonist with meals to manage nausea.

C) Refer the patient to a podiatrist for specialized foot care.

D) Encourage the patient to increase her physical activity to over 150 minutes per week.

A patient with a history of type 2 diabetes and peripheral neuropathy is being treated with gabapentin for neuropathic pain. She presents with new symptoms of persistent nausea and occasional vomiting. Which nursing intervention should be prioritized to address the patient's current condition while ensuring effective diabetes management?

B) Educate the patient on the importance of maintaining adequate hydration and suggest small, frequent meals.

A) Instruct the patient to stop gabapentin immediately to prevent further nausea and vomiting.

B) Educate the patient on the importance of maintaining adequate hydration and suggest small, frequent meals.

C) Recommend discontinuing the GLP-1 receptor agonist to eliminate gastrointestinal side effects.

D) Suggest increasing the gabapentin dosage to control neuropathic symptoms better.

A patient with diabetic neuropathy is experiencing persistent nausea and occasional vomiting, which has complicated adherence to her medication and dietary regimen. As a nurse, what is the most appropriate intervention to prioritize in this situation?

C) Collaborate with the healthcare provider to adjust the antiemetic treatment plan and ensure adequate hydration.

A) Educate the patient on the importance of taking gabapentin with food to reduce gastrointestinal side effects.

B) Recommend the patient to discontinue the GLP-1 receptor agonist until nausea resolves.

C) Collaborate with the healthcare provider to adjust the antiemetic treatment plan and ensure adequate hydration.

D) Increase the gabapentin dose to manage neuropathic pain effectively, despite nausea.

A patient with diabetes presents with symptoms of orthostatic hypotension, tachycardia, and worsening renal function. Which adjustment to the patient's care plan should the nurse prioritize to address these concerns?

C) Recommend dietary sodium increase to counteract orthostatic hypotension.

A) Increase the dosage of antihypertensive medication.

B) Initiate a fluid restriction to manage mild hyponatremia.

C) Recommend dietary sodium increase to counteract orthostatic hypotension.

D) Discontinue all antihypertensive medications to prevent further renal impairment.

A patient with diabetes presents with symptoms of orthostatic hypotension, tachycardia, and worsening renal function. Which nursing intervention is most appropriate to prioritize in the management of this patient's symptoms?

D) Adjust the patient's antihypertensive medication to improve blood pressure regulation.

A) Increase fluid intake to address orthostatic hypotension and prevent dehydration.

B) Educate the patient on how to rise slowly from a seated position to reduce dizziness.

C) Administer a beta-blocker to manage tachycardia and improve heart rate control.

D) Adjust the patient's antihypertensive medication to improve blood pressure regulation.

A patient with orthostatic hypotension and potential autonomic neuropathy has shown improvement in blood pressure and heart rate after changes to her antihypertensive regimen. However, she continues to experience intermittent dizziness and fatigue. Her lab results show mild hyponatremia. What should the nurse prioritize when planning her care?

B) Monitor the patient's sodium levels and review diuretic use with the healthcare team.

A) Encourage the patient to increase fluid intake to address dizziness.

B) Monitor the patient's sodium levels and review diuretic use with the healthcare team.

C) Advise the patient to reduce physical activity to prevent dizziness.

D) Implement fall precautions due to the patient's reported dizziness.

A patient with orthostatic hypotension and potential autonomic neuropathy is being monitored after changes to her antihypertensive regimen. Her blood pressure upon standing improves to 120/75 mmHg, but she still reports intermittent dizziness and fatigue. What is the most appropriate nursing intervention to address her symptoms?

A) Encourage the patient to increase fluid intake and consume small, frequent meals.

B) Instruct the patient to perform leg exercises before standing.

C) Recommend the patient to take her antihypertensive medication before bedtime.

D) Advise the patient to reduce sodium intake further to manage blood pressure.

Hyperglycemia - Nursing Case Study

Pathophysiology

• Primary mechanism: Insufficient insulin production or secretion by pancreatic beta cells leads to decreased glucose uptake by cells, resulting in elevated blood glucose levels.

• Secondary mechanism: Insulin resistance in peripheral tissues, often due to obesity or genetic factors, impairs glucose utilization, further contributing to elevated blood glucose.

• Key complication: Chronic hyperglycemia can cause damage to blood vessels, increasing the risk of cardiovascular diseases, neuropathy, and nephropathy, highlighting the importance of effective blood sugar management.

Patient Profile

Demographics:

52-year-old female, accountant

History:

• Type 2 Diabetes Mellitus diagnosed 10 years ago

• Hypertension, Hyperlipidemia

• Current medications: Metformin 1000 mg BID, Lisinopril 20 mg daily, Atorvastatin 40 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent fatigue and blurred vision

• Key symptoms: Increased thirst, frequent urination, occasional headaches, tingling sensation in feet

• Vital signs: Blood pressure 145/90 mmHg, heart rate 98 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, blood glucose 250 mg/dL

Section 1

As the healthcare team continues to monitor the patient's condition, a new set of laboratory results reveals further insights into her health status. Her HbA1c level, a key indicator of long-term blood glucose control, is reported at 9.2%, significantly higher than the target of less than 7%. This result suggests that her diabetes management plan is currently inadequate, contributing to sustained hyperglycemia and increasing the risk of complications. Additionally, a lipid panel shows elevated LDL cholesterol levels at 140 mg/dL, despite the patient's adherence to atorvastatin therapy, indicating persistent dyslipidemia. These findings necessitate a reassessment of her current treatment regimen to better manage her blood sugar and lipid levels.

Moreover, a comprehensive foot examination is conducted due to the patient's reported tingling sensation in her feet. The assessment reveals decreased sensation using a monofilament test, suggesting the early onset of peripheral neuropathy, a common complication of poorly controlled diabetes. This finding underscores the critical importance of stringent glycemic control to prevent further nerve damage and the development of more severe complications such as diabetic foot ulcers.

These diagnostic results prompt a discussion among the healthcare team regarding potential adjustments to the patient's medication regimen and lifestyle modifications. Consideration is given to the addition of a GLP-1 receptor agonist or SGLT2 inhibitor to her diabetes treatment plan, which may provide better glycemic control and cardiovascular benefits. Additionally, reinforcing the importance of dietary modifications, regular physical activity, and consistent follow-up appointments becomes essential in addressing her current health challenges and preventing the progression of diabetic complications.

Section 2

As the healthcare team implements the revised diabetes management plan, they opt to add a GLP-1 receptor agonist to the patient's regimen. This decision is made to help improve her glycemic control while also offering potential cardiovascular benefits, given her elevated LDL cholesterol levels. The patient is educated on the importance of adherence to the new medication and is encouraged to maintain a balanced diet and engage in regular physical activity, with a target of at least 150 minutes of moderate-intensity exercise per week.

Two weeks following the initiation of the new treatment, the patient returns for a follow-up appointment. Her vital signs show a blood pressure of 130/85 mmHg, heart rate of 78 bpm, and a weight loss of 3 pounds, indicating an initial positive response. However, she reports experiencing occasional nausea, a known side effect of the GLP-1 receptor agonist. The healthcare team discusses strategies to manage this side effect, such as taking the medication with meals and adjusting the timing of doses.

A repeat laboratory evaluation reveals a slight improvement in her fasting blood glucose levels, now averaging around 140 mg/dL, compared to previous readings of 180 mg/dL. However, her LDL cholesterol remains elevated at 135 mg/dL, suggesting the need for further adjustment in her lipid management strategy. The patient expresses concerns about her persistent tingling sensation in her feet, despite the improved glucose levels. This prompts the team to consider additional interventions, such as a referral to a podiatrist for specialized foot care and possibly initiating a low-dose gabapentin to address neuropathic symptoms. These developments highlight the ongoing challenges of managing diabetes and its complications and underscore the necessity of a comprehensive, multidisciplinary approach to care.

Section 3

As the healthcare team continues to closely monitor the patient's progress, the focus shifts to her persistent tingling sensation in the feet, which raises concerns about diabetic neuropathy. To evaluate the extent of this complication, a series of diagnostic tests are conducted. The results reveal decreased vibratory sensation and reduced monofilament test scores in both feet, confirming the suspicion of peripheral neuropathy. Meanwhile, her recent hemoglobin A1c level shows a slight improvement, now at 7.8% from a previous 8.5%, reflecting some progress in glycemic control, though still above the target of under 7%.

Given these findings, the healthcare team decides to initiate a low-dose gabapentin, aiming to alleviate the neuropathic pain and improve her quality of life. The patient is advised to start with a nighttime dose to minimize daytime drowsiness, a common side effect. In parallel, the team emphasizes the importance of preventive foot care, recommending daily inspection of her feet, wearing appropriate footwear, and maintaining good blood glucose control to prevent further complications.

Despite these interventions, the patient returns a month later with new complaints of persistent nausea and occasional vomiting, complicating her adherence to the prescribed medications and diet. Recognizing the potential impact of these symptoms on her overall health, the team explores alternative antiemetic options and considers reducing the GLP-1 receptor agonist dosage temporarily. They also stress the importance of small, frequent meals and adequate hydration. This scenario reinforces the necessity for continual reassessment and adaptation of the management plan to address emerging challenges and optimize the patient's outcomes.

Section 4

A few weeks later, the patient presents to the clinic with an exacerbation of her previous symptoms and some new complaints. She reports increased fatigue, a sensation of heart palpitations, and has noticed more frequent episodes of dizziness, particularly when standing up. Her blood pressure upon rising from a seated position drops from 130/85 mmHg to 110/70 mmHg, suggesting orthostatic hypotension. Additionally, her heart rate is noted to be tachycardic at 102 beats per minute. Given these findings, the healthcare team is concerned about the possibility of autonomic neuropathy, a complication associated with diabetes that can affect blood pressure and heart rate regulation.

Laboratory tests reveal a slight worsening of her renal function, with her serum creatinine rising to 1.4 mg/dL from a previous 1.2 mg/dL and eGFR showing a mild decline. This renal change, coupled with her orthostatic symptoms, prompts the team to consider adjustments to her medication regimen, specifically re-evaluating her antihypertensive therapy and the dosing of medications that may affect her renal function. Additionally, given her persistent nausea and vomiting, the team checks her electrolyte levels, which reveal mild hyponatremia at 133 mEq/L.

These developments necessitate a careful re-assessment of her treatment plan. The focus shifts towards optimizing her cardiovascular health and renal protection, alongside managing her diabetic complications. The healthcare team devises a strategy that includes possibly revising her antihypertensive prescriptions to mitigate orthostatic hypotension, reinforcing dietary modifications to address her electrolyte imbalances, and ensuring close monitoring of her renal function. This approach underscores the need for a comprehensive and adaptive management plan, integrating multiple facets of her condition to improve her overall health and prevent further progression of complications.

Section 5

The healthcare team decides to focus on the patient's orthostatic hypotension and potential autonomic neuropathy by closely monitoring her cardiovascular system. During the initial assessment findings after implementing changes to her antihypertensive regimen, the patient's blood pressure readings are carefully documented. A few days after the medication adjustments, her blood pressure upon standing shows some improvement, stabilizing at 120/75 mmHg, and her standing heart rate decreases slightly to 98 beats per minute. Despite these positive changes, the patient still reports intermittent dizziness and fatigue, which suggests that while the intervention is partially effective, further adjustments may be needed.

Concurrently, the team evaluates the patient's renal function and electrolyte balance in response to dietary modifications and medication changes. Her serum creatinine level stabilizes at 1.3 mg/dL, indicating a halt in the decline of her renal function, and her eGFR remains steady. However, her mild hyponatremia persists, with sodium levels fluctuating between 133-134 mEq/L. This necessitates a more tailored nutritional plan focusing on electrolyte-rich foods and possibly reviewing her diuretic use, which could be contributing to her sodium imbalance.

The healthcare team is encouraged by the improvements but remains vigilant, understanding the delicate balance required in managing her complex condition. They plan to continue with frequent follow-ups to reassess her cardiovascular and renal status, monitor for further signs of autonomic dysfunction, and adjust her treatment plan as necessary. This comprehensive approach aims to prevent further complications and enhance her quality of life, underscoring the importance of an integrated, patient-centered care strategy.